Form 4 for RNAZ Transcode Therapeutics, Inc.
Accepted 2022-06-17 00:00:00 ET · period of report 2022-06-16 · accession 0001104659-22-072369 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-17 | 2022-06-16 | RNAZ | Fitzgerald Thomas A | CFO, Dir | P - Purchase | $1.27 | +12.0K | 139.4K | +9% | +$15.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-16 | P | A | 12,000 | $1.27 | 139,377 | D | — | — |